Central reinforcing effects of ethanol are blocked by catalase inhibition.
Recent studies have systematically indicated that newborn rats are highly sensitive to ethanol's positive reinforcing effects. Central administrations of ethanol (25-200mg %) associated with an olfactory conditioned stimulus (CS) promote subsequent conditioned approach to the CS as evaluated through the newborn's response to a surrogate nipple scented with the CS. It has been shown that ethanol's first metabolite, acetaldehyde, exerts significant reinforcing effects in the central nervous system. A significant amount of acetaldehyde is derived from ethanol metabolism via the catalase system. In newborn rats, catalase levels are particularly high in several brain structures. The present study tested the effect of catalase inhibition on central ethanol reinforcement. In the first experiment, pups experienced lemon odor either paired or unpaired with intracisternal (IC) administrations of 100mg% ethanol. Half of the animals corresponding to each learning condition were pretreated with IC administrations of either physiological saline or a catalase inhibitor (sodium-azide). Catalase inhibition completely suppressed ethanol reinforcement in paired groups without affecting responsiveness to the CS during conditioning or responding by unpaired control groups. A second experiment tested whether these effects were specific to ethanol reinforcement or due instead to general impairment in learning and expression capabilities. Central administration of an endogenous kappa opioid receptor agonist (dynorphin A-13) was used as an alternative source of reinforcement. Inhibition of the catalase system had no effect on the reinforcing properties of dynorphin. The present results support the hypothesis that ethanol metabolism regulated by the catalase system plays a critical role in determination of ethanol reinforcement in newborn rats.
Nizhnikov
Michael E
ME
Center for Developmental Psychobiology, Department of Psychology, Binghamton University--SUNY, Binghamton, NY 13902-6000, USA. mnizhnikov@binghamton.edu
Molina
Juan C
JC
Spear
Norman E
NE
D000079:Acetaldehyde / Q000494:pharmacology; D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D000833:Animals, Suckling / Q000502:physiology*; D002374:Catalase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects* / Q000502:physiology; D003214:Conditioning, Classical / Q000187:drug effects / Q000502:physiology*; D004399:Dynorphins / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D000431:Ethanol / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D007276:Injections, Intraventricular; D008297:Male; D009812:Odorants; D010446:Peptide Fragments / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012054:Reinforcement, Psychology; D012903:Smell / Q000502:physiology*; D019810:Sodium Azide / Q000494:pharmacology*; D012965:Sodium Chloride / Q000008:administration & dosage / Q000494:pharmacology
D000701:Analgesics, Opioid; D004791:Enzyme Inhibitors; D010446:Peptide Fragments; D000431:Ethanol; D012965:Sodium Chloride; C026843:dynorphin (1-13); D004399:Dynorphins; D019810:Sodium Azide; D002374:Catalase; D000079:Acetaldehyde